Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: -

S-e-banken Legemiddel

+ Add to Watchlist

SELEGEM:NO

58.02 NOK 0.97 1.65%

As of 02:59:30 ET on 05/22/2015.

Snapshot for S-e-banken Legemiddel (SELEGEM)

Year To Date: +13.80% 3-Month: +8.55% 3-Year: +37.40% 52-Week Range: 36.36 - 61.48
1-Month: -3.70% 1-Year: +60.27% 5-Year: +24.86% Beta vs OBX: 0.53

Mutual Fund Chart for SELEGEM

No chart data available.
  • SELEGEM:NO 58.02
  • 1M
  • 1Y
Interactive SELEGEM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SELEGEM

SEB Legemiddel Fund is an open-end fund incorporated in Sweden. The Fund invests primarily in equities and equity related securities of major pharmaceutical, medical technology, biotechnology and medical services companies.

Inception Date: 09-15-1999 Telephone: 47-810-01-050
Managers: -
Web Site: www.seb.no/fonder

Fundamentals for SELEGEM

NAV (on 2015-05-22) 58.02
Assets (M) (on 2010-05-28) 382.75
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for SELEGEM

No dividends reported

Fees & Expenses for SELEGEM

Front Load -
Back Load -
Current Mgmt Fee -
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for SELEGEM

Filing Date: 12/31/2014
Name Position Value % of Total
Roche Holding AG 329,892 701,461,000 6.958%
Johnson & Johnson 856,846 701,411,000 6.958%
Gilead Sciences Inc 801,500 591,417,000 5.867%
Amgen Inc 444,534 554,315,000 5.499%
Pfizer Inc 2,122,117 517,476,000 5.133%
AbbVie Inc 1,006,022 515,364,000 5.112%
Shire PLC 699,238 386,892,000 3.838%
HCA Holdings Inc 599,900 344,650,000 3.419%
Universal Health Services Inc 379,100 330,184,000 3.275%
Cigna Corp 401,400 323,369,000 3.208%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil